Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 21, 2024Clinical Surgical OncologyOpen Access

Complete surgical excision of primary breast angiosarcoma in a teenager resulted in no recurrence or metastasis at 1 year, despite the inability to complete adjuvant chemotherapy.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Primary angiosarcoma of the breast presents diagnostic and management challenges due to unclear pathogenesis, lacking consensus on optimal treatment, and controversy surrounding adjuvant therapies.

Population

A teenager with thalassemia and primary angiosarcoma of the breast

Comparison

Complete surgical excision followed by incomplete chemotherapy

Design

Case report and comprehensive review

Follow-up

1-year

Key result

Complete surgical excision of primary breast angiosarcoma in a teenager resulted in no recurrence or metastasis at 1 year, despite the inability to complete adjuvant chemotherapy.

Authors

MHMengjia HanXXXiaoyun XiaoZWZhuo Wu

Discussion

Loading...

Member takes

Overview

Single case supports exploring surgery-alone strategies in breast angiosarcoma; leaves open need for prospective validation before practice change.

Study Design

Type

Case Report (n=1)

Structured PICO

P
Population
A teenager with thalassemia and primary angiosarcoma of the breast who underwent complete surgical excision and was followed for 1 year.
I
Intervention
Complete surgical excision followed by incomplete chemotherapy
O
Outcome
Recurrence or metastasishard clinical

Complete surgical excision may be sufficient for 1-year recurrence-free survival in primary angiosarcoma of the breast even when adjuvant chemotherapy cannot be completed.

Cite This Study

Han et al. (2024) conducted a case report in Primary angiosarcoma of the breast (n=1). Complete surgical excision was evaluated on Recurrence or metastasis. Complete surgical excision of primary breast angiosarcoma in a teenager resulted in no recurrence or metastasis at 1 year, despite the inability to complete adjuvant chemotherapy.

synapsesocial.com/papers/6a7db149cecc27a187a1463bhttps://doi.org/10.1016/j.cson.2024.100062
View Full Paper
Ask AI
Bookmark
Share